Showing results (191-200 of 270) with videos related to

Sort By:
Pageof 27
Diabetes, Obesity & Metabolism|October 6, 2022
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE studyHelena Bleken Østergaard, Valerie Humphreys, Ellen Margo Hengeveld, et al.
Ophthalmology Science|January 3, 2024
Bruch's Membrane Calcification in Pseudoxanthoma Elasticum: Comparing Histopathology and Clinical ImagingSara Risseeuw, Matthew G Pilgrim, Sergio Bertazzo, et al.
Diabetes Care|June 4, 2015
Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different LocationsManon C Stam-Slob, Yolanda van der Graaf, Gert Jan de Borst, et al.
Obesity Research & Clinical Practice|December 4, 2022
Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Ynte M Ruigrok, et al.
Orphanet Journal of Rare Diseases|February 7, 2024
The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trialBirgitta Mg Snijders, Gini Mathijssen, Mike Jl Peters, et al.
European Journal of Internal Medicine|April 7, 2022
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetesMarieke de Vries, Fatima El-Morabit, Karel J van Erpecum, et al.
Neurobiology of Aging|January 26, 2015
Hemoglobin, hematocrit, and changes in cerebral blood flow: the Second Manifestations of ARTerial disease-Magnetic Resonance studyPieternella H van der Veen, Majon Muller, Koen L Vincken, et al.
Cardiovascular Diabetology|July 20, 2016
The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular diseaseSophie H Bots, Yolanda van der Graaf, Hendrik M W Nathoe, et al.
Plos One|April 7, 2022
Chronic kidney disease and atrial fibrillation: A dangerous combinationGurbey Ocak, Meriem Khairoun, Othman Khairoun, et al.
Heart (British Cardiac Society)|March 15, 2020
Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular diseaseSteven H J Hageman, Gert Jan de Borst, Johannes A N Dorresteijn, et al.
Pageof 27